Pfizer (PFE) EBT Margin (2009 - 2026)
Pfizer (PFE) reported EBT Margin of -4.34% for Q2 2026, down 25.12 percentage points from 20.77% a year earlier and down 26.28 percentage points from the prior quarter.
Pfizer (PFE) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 28, 2026, Pfizer's EBT Margin came in at 6.61%, down 9.89 percentage points year-over-year; for FY2025, it came in at 12.02%, down 0.59 percentage points from FY2024.
- EBT Margin has a five-year change of -4.88 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 12.61% in FY2024 (+10.83 pp), 1.78% in FY2023 (-32.55 pp), 34.33% in FY2022 (+4.42 pp) and 29.91% in FY2021 (+13.01 pp).
- Five-year quarterly EBT Margin spans a low of -28.34% in Q4 2023 and a high of 41.26% in Q2 2022.
- Year over year, EBT Margin gained in three of the last seven quarters, with an average year-over-year change of +1.11 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2024 (a gain of 28.28 percentage points); the low point was Q2 2026 (a drop of 25.12 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.94% (Q1 2026), -9.35% (Q4 2025) and 20.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 31.50% |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -4.34% |
| Mar 29, 2026 | 21.94% |
| Dec 31, 2025 | -9.35% |
| Sep 28, 2025 | 20.02% |
| Jun 29, 2025 | 20.77% |
| Mar 30, 2025 | 20.31% |
| Dec 31, 2024 | -0.06% |
| Sep 29, 2024 | 26.64% |
| Jun 30, 2024 | -0.78% |
| Mar 31, 2024 | 22.99% |
| Dec 31, 2023 | -28.34% |
| Jul 2, 2023 | 17.44% |
| Apr 2, 2023 | 33.92% |
| Jul 3, 2022 | 41.26% |
| Apr 3, 2022 | 35.27% |
| Oct 3, 2021 | 32.63% |
| Jul 4, 2021 | 36.77% |
| Apr 4, 2021 | 39.21% |
| Dec 31, 2020 | 5.23% |
| Sep 27, 2020 | 5.55% |
Pfizer EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();